Attraction and activation of dendritic cells at the site of tumor elicits potent antitumor immunity.
about
Dendritic Cells in Oncolytic Virus-Based Anti-Cancer TherapyPromising oncolytic agents for metastatic breast cancer treatmentCCL21 Chemokine Therapy for Lung Cancer.Beta-defensin 2 enhances immunogenicity and protection of an adenovirus-based H5N1 influenza vaccine at an early timeToll-like receptor mediated regulation of breast cancer: a case of mixed blessings.Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles.β-defensin 2 as an adjuvant promotes anti-melanoma immune responses and inhibits the growth of implanted murine melanoma in vivo.Adenoviral vector expressing murine β-defensin 2 enhances immunogenicity of an adenoviral vector based H5N1 influenza vaccine in aged mice.Expression of FMS-like tyrosine kinase 3 ligand by oncolytic herpes simplex virus type I prolongs survival in mice bearing established syngeneic intracranial malignant glioma.New perspectives in cancer virotherapy: bringing the immune system into play.Chemokines: can effector cells be redirected to the site of the tumor?Liposomes targeting tumour stromal cells.Recent advances in oncolytic virus design.Arming oncolytic viruses to leverage antitumor immunity.Convergent evolution of defensin sequence, structure and function.Antitumor efficacy of oncolytic herpes simplex virus adsorbed onto antigen-specific lymphocytes.Granulocyte-macrophage stimulating factor (GM-CSF) increases circulating dendritic cells but does not abrogate suppression of adaptive cellular immunity in patients with metastatic colorectal cancer receiving chemotherapy.A role for B cells in facilitating defense against an NK cell-sensitive lung metastatic tumor is revealed by stress.Tumor Restrictions to Oncolytic Virus.Feasibility of Applying Helper-Dependent Adenoviral Vectors for Cancer Immunotherapy.
P2860
Q26774345-6335F0B3-768D-4F1F-A19D-80FD9B8DED4DQ26830620-8777786C-92A8-4BB4-BF9D-1170BB2BDC4AQ28248811-C53E0AE0-A82F-4B15-BBB3-8CCD212DCD94Q30353770-F078EA17-23EA-45D0-95FB-9337B0E0EE14Q33658124-D3710428-0365-4336-A098-605649914C2BQ33906116-394AB224-C265-45AC-AC7C-07D8DF4289D7Q34163480-5D48F9D3-531B-4BDD-A8ED-CA721334BF68Q37331004-E00B7E5E-FDE7-485F-BE66-542B7F983522Q37579001-9ECB77C8-6AAC-4681-9A48-A9C2FCD09479Q37773253-E322BBCE-BC86-4E3F-AA51-FAB079AA5053Q37778693-F480A9F6-A11C-4265-BF34-232ABEC7DAD3Q37799613-8EB9235A-DEB6-479B-A315-FE278939CCC4Q37865172-FAEEFB50-C965-4196-AD37-E1ABD407EE76Q38470166-3CF4F68D-0DA0-4AEB-812A-1F43B978F693Q38936327-04C7F16F-37D9-4BF5-B106-30A7CE68E830Q39405521-840192A9-2F78-4822-9524-618FE3ADF371Q41358662-1A910FF0-2E12-46AD-BDAC-F8BAAEFA6FA9Q47387265-B868D8F4-C3CF-4FC3-8FB6-7AC7491DB0FBQ51846287-D814DB0E-D4BF-4712-84E4-0A42843AACE6Q51847569-D07AEC93-94BB-4095-847B-4E29564EF075
P2860
Attraction and activation of dendritic cells at the site of tumor elicits potent antitumor immunity.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Attraction and activation of d ...... its potent antitumor immunity.
@ast
Attraction and activation of d ...... its potent antitumor immunity.
@en
type
label
Attraction and activation of d ...... its potent antitumor immunity.
@ast
Attraction and activation of d ...... its potent antitumor immunity.
@en
prefLabel
Attraction and activation of d ...... its potent antitumor immunity.
@ast
Attraction and activation of d ...... its potent antitumor immunity.
@en
P2093
P2860
P356
P1433
P1476
Attraction and activation of d ...... its potent antitumor immunity.
@en
P2093
Lisa Rollins
Melissa Aldrich
Natalia Lapteva
Si-Yi Chen
Tatiana Goltsova
Wenhong Ren
Xue F Huang
P2860
P304
P356
10.1038/MT.2009.111
P577
2009-06-16T00:00:00Z